Global Cerebral Embolic Protection Devices For TAVI Market Size By Type (Keystone Hearts Triguard Device, Clarets Sentinel System), By Application (Hospital, Home), By Geographic Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Cerebral Embolic Protection Devices For TAVI Market Size By Type (Keystone Hearts Triguard Device, Clarets Sentinel System), By Application (Hospital, Home), By Geographic Scope And Forecast
Cerebral Embolic Protection Devices For TAVI Market Size And Forecast
Cerebral Embolic Protection Devices For TAVI Market size was valued at USD 52.08 Million in 2023 and is projected to reach USD 257.7 Million by 2030, growing at a CAGR of 25.9% from 2024 to 2030.
An increase in the prevalence of cardiovascular illnesses, as well as an increase in the elderly population, are driving the market. The entire market has grown due to an increase in the use of cerebral embolic protection devices in advanced operations. Furthermore, the government’s increased investments in the healthcare business are predicted to push the market’s expansion globally. Furthermore, technological breakthroughs that have resulted in the creation of enhanced embolic protection devices for TAVI, such as CLEAN-TAVI, have can be a major market driver.
Global Cerebral Embolic Protection Devices For TAVI Market Definition
The primary treatment for severe aortic stenosis that is inoperable or has a high surgical risk is transcatheter aortic valve implant (TAVI). Diffusion-weighted MRI studies show that following TAVI, there are a few silent embolic cerebral infarcts that cause mental impairment. During travel, embolic safety devices are employed to provide mechanical protection against the debris that causes cerebral embolism. TAVI-related cerebrovascular events have been minimized because of these devices. Mesh filters are used in cerebral embolic protection systems to prevent embolic particles from entering the carotid arteries. Clarets Sentinel System, Keystone Hearts Triguard Device, and Embrella Embolic Deflector are three types of cerebral embolic protection devices.
The pore size, deployment site, and chemical makeup of these devices are all different. Cerebral embolic protection devices have been demonstrated to be successful in removing debris and reducing the extent of ischemic embolic lesions, reducing the likelihood of clinically obvious cerebrovascular accidents. The market is divided majorly based on type Clarets Sentinel System, Keystone Hearts Triguard Device, and Umbrella Embolic Deflector are the three segments of the market. A Clarets Sentinel System is just an embolic prevention gadget that uses the concept of inertial separation to keep potentially dangerous materials out of the bloodstream. During the TAVI process, the system could be employed for Cerebral Embolic Protection (CEP).
The Triguard Device from Keystone Hearts is a protective device that aids in the protection of the brain throughout cardiopulmonary bypass. In patients having surgical operations, it also lowers the risk of brain damage and cerebral hemorrhage. Throughout transcatheter aortic valve implantation (TAVI) surgeries, this device is utilized to prevent cerebral embolism. The Umbrella Embolic Deflector is just an umbrella-shaped apparatus that prevents embolization by using a catheter and deflected blood flow. It keeps its shape by keeping air inside, which also helps to keep emboli from traveling through the brain veins. The Umbrella Embolic Deflector is a transcatheter aortic valve replacement embolic protection device (TAVR). They’re widely used in hospitals.
The purpose of using Global Cerebral Embolic Protection Devices in hospitals for TAVI is to safeguard the brain before, during, and after the procedure (TAVR). A balloon inflates in the left atrium or inside the heart as part of the device. and at home; The goal of using Global Cerebral Embolic Protection Devices for TAVI at home is to lower the risk of stroke and heart attack. It allows patients to stay at home rather than go to the hospital. TAVI, which was launched in 2002, is expanding in terms of scientific manufacturing and innovative activity to revolutionize the management of aortic stenosis in cardiology, with significant implications for health management due to the improved price of this new technology and improved efficiency in people’s healthcare.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Cerebral Embolic Protection Devices For TAVI Market Overview
An increase in the prevalence of cardiovascular illnesses, as well as an increase in the elderly population, are driving the global market. The entire market has grown due to an increase in the use of cerebral embolic protection devices in advanced operations. Furthermore, the government’s increased investments in the healthcare business are predicted to push the market’s expansion globally. Since the patients who were confirmed for severe aortic stenosis (AS) were directed to TAVI under the leadership of the cardiology department/team.
COVID19 has been a major driver of the market throughout the years 2019-2021. TAVI was a dependable and successful treatment alternative that served as the foundation for TAVI practice guidelines during COVID-19. Approximately 50% of patients had SAVR, however, during COVID-19 (2020), this rate reduced to 34%, indicating a shift in procedure from SAVR to minimally invasive TAVI. Furthermore, technological breakthroughs that have resulted in the creation of enhanced embolic protection devices for TAVI, such as CLEAN-TAVI, have can be a major market driver.
There are some constraints and hurdles that are impeding overall market expansion. The market’s growth is projected to be limited by factors such as the high cost of equipment and procedures. Nonetheless, technological improvements are resulting in the development of improved and effective embolic protection devices for TAVI, such as CLEAN-TAVI, which is expected to bring good future chances.
Global Cerebral Embolic Protection Devices For TAVI Market Segmentation Analysis
The Global Cerebral Embolic Protection Devices For TAVI Market is Segmented On The Basis Of Type, Application, And Geography.
Cerebral Embolic Protection Devices For TAVI Market, By Type
• Keystone Hearts Triguard Device• Clarets Sentinel System• Embrella Embolic Deflector
Based On Type, The Market is Segmented into Keystone Hearts Triguard Device, Clarets Sentinel System, and Embrella Embolic Deflector. A Clarets Sentinel System is just an embolic prevention gadget that uses the concept of inertial separation to keep potentially dangerous materials out of the bloodstream. During the TAVI process, the system could be employed for Cerebral Embolic Protection (CEP). The Triguard Device from Keystone Hearts is a protective device that aids in the protection of the brain throughout cardiopulmonary bypass. In patients having surgical operations, it also lowers the risk of brain damage and cerebral hemorrhage. The Umbrella Embolic Deflector is just an umbrella-shaped apparatus that prevents embolization by using a catheter and deflected blood flow. It keeps its shape by keeping air inside, which also helps to keep emboli from traveling through the brain veins.
Cerebral Embolic Protection Devices For TAVI Market, By Application
• Hospital• Home
Based On Application, The Market is Segmented into Hospital And Home. The purpose of using Global Cerebral Embolic Protection Devices in hospitals for TAVI is to safeguard the brain before, during, and after the procedure (TAVR). A balloon inflates in the left atrium or inside the heart as part of the device. The goal of using Worldwide Cerebral Embolic Protection Devices for TAVI at home is to lower the risk of stroke and heart attack. It allows patients to stay at home rather than go to the hospital. They will have a better living experience as a result, and their stress levels will be significantly reduced. TAVI in-home global cerebral embolic protection devices are used to lower the risk of stroke caused by blood clots.
Cerebral Embolic Protection Devices For TAVI Market, By Geography
• North America• Europe• Asia Pacific• Rest of the world
On the basis of Geography, The Global Cerebral Embolic Protection Devices For TAVI Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The Asia Pacific is expected to be the dominant market for cerebral embolic protection devices in Latin America. The market is predicted to grow rapidly, owing to an increase in the senior population and technological developments in TAVI implants in developed nations such as the United States and the United Kingdom. The Asia Pacific region has a large population that is rapidly increasing, notably in emerging countries like China and India. Medical products, such as Cerebral Embolic Protection, are in high demand as a result of this.
Key Players
The “Global Cerebral Embolic Protection Devices For TAVI Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Keystone Heart, Claret Medical, Inc., Edwards Lifesciences Corporation, and others.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Key Developments
• On March 10, 2020, The TriGUARD 3 TM Cerebral Embolic Protection (CEP) Device has received European CE Mark from Keystone Heart Ltd., a Venus MedTech Company. During Transcatheter Aortic Valve Implantation (TAVI) and other transcatheter cardiac procedures, the device is meant to divert embolic material away from cerebral circulation, reducing the risk of brain injury.
• The TriGUARD 3TM Cerebral Embolic Protection Device was used for the first time in a commercial case in the world, according to Keystone Heart, a Venus MedTech company.
• For $300 million, Venus MedTech (Hangzhou) Inc. bought a 100 percent stock interest and corresponding equity in Cardio valve Ltd. Cardio valve, established in Yehuda, Israel, makes the Cardio valve system, which is a transcatheter interventional replacement solution for mitral or tricuspid regurgitation.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2020-2030 |
BASE YEAR | 2023 |
FORECAST YEAR | 2024-2030 |
HISTORICAL PERIOD | 2020-2022 |
UNIT | Value (USD Million) |
KEY COMPANIES PROFILED | Keystone Heart, Claret Medical, Inc., and Edwards Lifesciences Corporation. |
SEGMENTS COVERED | • By Type• By Application• By Geography |
CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.